Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dipeptidyl-Peptidase 4 Inhibitors”

Showing 7 of 0 results

Not applicableStudy completedNCT04825795
What this trial is testing

DPP4 Inhibitor and Coronary Atherosclerosis in Patients Receiving Insulin Therapy

Who this might be right for
Diabetes Mellitus
The Catholic University of Korea 4,007
Post-approval studies (Phase 4)Looking for participantsNCT06875193
What this trial is testing

DM Treatment to Evaluate the Efficacy and Safety of Dapagliflozin or Pioglitazone in Patients with Type 2 Diabetes

Who this might be right for
Type2diabetes
Dong Wha Pharmaceutical Co. Ltd. 196
Early research (Phase 1)Study completedNCT02620592
What this trial is testing

Clinical Study to Evaluate the Safety, Tolerability and Pharmacokinetics (PKs) of ZYDPLA1 Following Oral Administration in Healthy Volunteers

Who this might be right for
Diabetes Mellitus
Zydus Lifesciences Limited 84
Large-scale testing (Phase 3)Study completedNCT06770894
What this trial is testing

DPP4-Inhibitors and Bone Metabolism in Diabetes

Who this might be right for
OsteoporosisBone Loss, PostmenopausalDiabetes Mellitus Type 2
Azienda Policlinico Umberto I 132
Large-scale testing (Phase 3)Study completedNCT01368081
What this trial is testing

Empagliflozin (BI 10773) Comprehensive add-on Study in Japanese Subjects With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 1,162
Testing effectiveness (Phase 2)Looking for participantsNCT07365592
What this trial is testing

Neoadjuvant Chemotherapy, Anti-PD-1 Antibody and Sitagliptin for Locally Advanced pMMR CRC

Who this might be right for
Colorectal Cancer
Second Affiliated Hospital, Zhejiang University, School of Medicine 138
Post-approval studies (Phase 4)UnknownNCT02528019
What this trial is testing

Metabolic and Cardiovascular Effects of Dipeptidyl Peptidase-4 (DPP-4) or Sodium-glucose Co-transporter Type 2 (SGLT2) Inhibitors

Who this might be right for
Effects of the DPP-4 Inhibitors or SGLT2 Inhibitors on the Protective Actions for Diabetic Complications
Kurume University 100

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation